Get complete information related to latest Tofisopam Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Tofisopam Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Tofisopam Tenders.
Tender For supply of drug eluting stent -sirolimous drug with biodegrable polymer on cobalt chromium platform with active coating. size ranging from length 08 mm to 48 mm and width 2.25 mm to 5.0 mm. the quoted stent to be at least dcgi approved and three years efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented/published in peer reviewed scientific journals. the documents pertaining to the efficacy and safety of the stent should be enclosed for the brand that is offered in the tender bid. replacement warranty against any manufacturing defect noted onthe o.t. table. the original company brochure mentioning the range of sizes (diameter & length) should besubmitted along with tender. [ai(2026-27), item code-no: s-62066, sl no.2010] ]
Tender For e-tender for procurement of essential drug items under table-a, for one year from the date of aoc. - amitriptyline hcl tab.i.p. 10mg., aripiprazole tab 5 mg, cefpodoxime oral suspension 50mg/5ml, cefpodoxime proxetil 200 mg tab i.p, ciprofloxacin hcl tab. i.p. 500mg (scored ), clindamycin inj. 600mg./ 4 ml amp/vial., doxycyclin capsules 100mg, glimipride 2 mg tab, ibuprofen i.p. 400 mg tab., isoniazid tab.i.p. 300mg, levetiracetam ip tab 500 mg, levetiracetam syrup 100 mg/ ml in 100 ml bottle, lignocaine hcl gel i.p 2% w/w, meropenem inj 500mg/vial, metformin tab 500 mg (sr/pr/er), o.r.s i.p. as powder for reconstitution,cont.:sod. chloride 2.6gm.,dextrose (anhydrous13.5gms ,pot.cl 1.5 & sod.citrate 2.9gms (total 20.5per packet)., omeprazole caps.i.p. 20mg., oseltamivir syrup ip (oseltamivir phosphate) 12 mg/ml, 75 ml phial, pantoprazole 40 mg. tab. (enteric coated), paracetamol 1000 mg tab., paracetamol i.p. 125 mg. tab., paracetamol i.p. 500 mg. tab., paracetamol i.p. 650 mg. tab. (scored), pramipexole tab 0.25mg, prednisolone tab 10 mg, propranolol hcl tablet i.p. 10mg, propranolol hcl tablet i.p. 40mg, salbutamol syrup i.p. 2mg./5ml., telmisartan tab 80 mg, tramadol hcl 50 mg tab., important note: 1. all prospective bidders are requested to quote the rate in boq as per accounting unit & item specification as mentioned in the table-a. wrong quoting of the rate in boq will be dealt with as per penal provisions of the t&c of the tender.2. tendered quantity is just a tentative quantity and should not be treated as final. it may increase or decrease, as per need of the state. keeping this in mind, the supplier is not allowed to seek termination of the rate contract after finishing supply of tendered quantity.3. quality of the product supplied, may be ascertained by testing / physical examination by the experts at any stage of the tender period.4. the prospective bidders of the said tender are requested to make a declaration in affidavit under annexure vi(b) in case of sole manufacturer/importer (i.e. proprietary in nature).5. if the item(s) under sole manufacturer / importer is (are) proprietary in nature, quarterly intimation is solicited from the approved bidders positively regarding the status of their item(s) proprietary in nature, otherwise their item(s) will be blocked in the smis.6. in case of tie bid, decision will be taken by the tia as per g.o. no. 2320-f(y), dated 07.06.2022 issued from finance department audit branch (group t).
Tender For supply of waiting bench individual bed types , auditorium chair , auditorium conference hall 150 desk and chair for 2 students , auditorium conference hall 100 desk and chair for 2 students , desk , waiting bench for 3 persons , sofa set 3 seater , platform bed , table and wall mounted table required lab item for medical purpose , for storage cubical post forming custom made frame and shutters only , for storage cubical post forming custom made , main desk , return desk , joining table rhs , mobile pedestal oxford cherry , back unit oxford cherry , main table with side unit , mid back chair , conference table 6 seater ta , 3 seater sofa fab brown , 1 seater sofa fab brown , attendent bed cum chair , single static push and pull type storage ss1 , single static push and pull type storage sl1 , single static push and pull type storage tm1 solid back panel , channels rails p1 by p2 chnl 2400 mm , channels rails p1 by p2 chnl 1600 mm , flod table , acousticical grid false ceiling , administrative block sls printed fabric ceiling , administrative block veneer ceiling paneling , veneer wall paneling , fluted veneer wall paneling , nilaya ray skin wall paper pattern , nilaya straight up wall paper pattern , mdf beading with c trim , fluted veneer ceiling paneling , subtex clouds nubby kontour grafix bild , liso spots nano plus bild , for auditorium astral plus malla clip- in melange bild , for guest house veneer ceiling paneling , for guest house fluted veneer ceiling paneling , for guest house veneer wall paneling , for guest house fluted veneer wall paneling , for guest house nilaya sabyasachi wall paper pattern , for gust house nilaya bolta apex cord wall paper pattern , for guest housemdf beading with c trim , for guest house marmofresco texture paint , reception table , dining table , wooden dining chair , curtains , king cot , single cot , bedside cabinet , drug trolley cart 12 drawer , emergency crash cart , examination couch with step stool , icu motorised bed with mattress 5 function height head trendlendurg and leg , instrument trolley , instrument medicine cabinet , iv stand 4 pole height adjustable , manual bed with mattress 4 function height head leg and trendlendurg , overbed table adjustable , step stool 2 step , strecher without height adjustment , stretcher with height adjustment hydraulic oxygen cylinder iv pole , wheel chair foldable , wheel chair with cushion , air mattress , gynec examination couch , mayos trolley , revolving stool with cushion top , autopsy table with motorised movement , wheelchair motorised
Tender For srphc82281240-coronary drug eluting stents with (1) stent on cobalt chromium alloy or platinum chromium alloy. (2) stent with coating of polymer carrier for active drug ( sirolimus, everolimus or zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm and length of the stent should be 12mm to 48mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval shouldbe enclosed in the tender bid. (9) the long term efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals. (10) the documents related to the efficacy and safety of the stent should be only for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent toa major government institute.[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]
Tender For srphc82281210-coronary drug eluting stents (1) single wire technology on cobalt based alloy platform (2) stent with coating of biolinx polymer carrier for active drug zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.25 mm to 4 mm and length of the stent from 12mm to 38 mm. (4) the strut thickness should be 81 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) five years long term efficacy and safety of the stent in terms of target vesselrevascularisation (tvr) and in-situ thrombosis (ist) should be documented / published inpeer reviewed scientific journals.(10) the documents pertaining to the efficacy and safety of the stent should be enclosed for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute.[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]
Tender For srphc82281275-des-abbreviated dapt long -coronary drug eluting stents with (1) platinum chromium alloy (2) coating of bioabsorbable polymer carrier for activedrug everolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm. the length of the stent should be from 12mm to 48 mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) the long term efficacy and safety of the stent, the rates of in-stent restenosis (isr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals. (10) safety of abbreviated (three month) dual antiplatelet therapy for high bleeding risk patients should be documented in peer reviewed journals. (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute. bis standards for the drug eluting stent are not available. (reference:bis catalogue ).[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]
Tender For srphc82281225-coronary drug eluting stents with (1) cobalt chromium alloy (2) coating of bioabsorbable polymer carrier with abluminal and gradient coating foractive drug shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm . the length of the stent should be from 12mm to 38 mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should bemonorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) the long term efficacy and safety of the stent, the rates of in-stent restenosis (isr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals. (10) safety of abbreviated (one month) dual antiplatelet therapy for high bleedingrisk patients should be documented in peer reviewed journals. (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute. bis standards for the drug eluting stent are not available. (reference:bis catalogue ).[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]
Tender For srphc82281280-des-pt/cr : coronary drug eluting stents (1) on platinum chromium platform (2) stent with coating of polymer carrier for active drug everolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter shouldbe from 2.5mm to 4mm and length of the stent from 12mm to 38 mm. (4) the strutthickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved bydcgi . the copy of dcgi approval should be enclosed in the tender bid. (9) the long termefficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals.(10) the documents pertaining to the efficacy and safety of the stent should be enclosed for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute.[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]